Condition
Cervical Cancer Stage IB2
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Completed1
Not Yet Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06836869Not ApplicableRecruitingPrimary
Modified Tumor-free Techniques Operation to Cervical Cancer
NCT07256977Not ApplicableNot Yet RecruitingPrimary
Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer
NCT07248878RecruitingPrimary
Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy
NCT04770090Not ApplicableCompleted
Research of Circulating Tumor Cells Released During Cervical Cancer Surgery
NCT03146039Phase 2Withdrawn
Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB
Showing all 5 trials